Executive Appointment

Sound Physicians Names Emil Engels Chief Physician Officer at Anesthesia Unit

Image
Sound Physicians Names Emil Engels Chief Physician Officer at Anesthesia Unit

Nashville – October 29, 2026 -- Sound Physicians has appointed Emil Engels, MD, MBA, as Chief Physician Officer for Sound Anesthesia, a newly created post that places a physician executive alongside a CRNA executive at the top of the unit's clinical leadership.

Engels joined in September and shares leadership with Chief Anesthetist Officer Noele Morse

Engels is a cardiac anesthesiologist with more than 25 years of experience leading anesthesia practices and healthcare organizations. He joined the medical group in September to work with Sound Anesthesia's physician leaders on operational excellence and clinical quality initiatives. He will work alongside Noele Morse, DNP, CRNA, the unit's Chief Anesthetist Officer. The same collaborative model extends to the associate-level roles.

Talos Hires Ex-Fidelity Digital Assets Exec Kelly Ye as Head of Research

Image
Talos Hires Ex-Fidelity Digital Assets Exec Kelly Ye as Head of Research

NEW YORK – October 29, 2026 -- Talos, the institutional technology and data provider for digital asset trading and portfolio management, has hired Kelly Ye as Head of Research, putting a dedicated leader over a research program that follows liquidity, market structure and onchain finance.

Ye brings nearly two decades of finance experience, including 14 years in traditional markets

Ye will be based in New York. She held investment leadership roles in digital assets at Avenir Group and Decentral Park Capital. She also held research and product leadership roles at Fidelity Digital Asset Management and CoinDesk Indices. Most recently, she was building Coinbridge, a company focused on bridging the capital gap for tokenized real-world assets.

Ye holds a bachelor's degree in Applied Mathematics from Peking University and a master's degree in Operations Research from MIT. She is a CFA charterholder.

Virtualitics Names Dr. Bert Mandelbaum Scientific Advisor

Image
Virtualitics Names Dr. Bert Mandelbaum Scientific Advisor

PASADENA – October 29, 2026 -- Virtualitics has appointed orthopedic surgeon Dr. Bert R. Mandelbaum as Scientific Advisor to shape its AI-driven medical readiness strategy for defense and government customers.

Mandelbaum to advise on injury prevention, recovery and return-to-performance

Mandelbaum will inform Virtualitics' medical and personnel readiness solutions, drawing on expertise in injury prevention, musculoskeletal health, recovery and return-to-performance programs. Virtualitics is targeting defense, government and other mission-critical sectors that want to optimize human performance and operational readiness.

ManpowerGroup Adds Ex-Pfizer Tech Chief Fonseca to Board

Image
ManpowerGroup Adds Ex-Pfizer Tech Chief Fonseca to Board

MILWAUKEE – October 29, 2026 -- ManpowerGroup (NYSE: MAN) has elected Lidia Fonseca, Pfizer's former Executive Vice President and Chief Digital and Technology Officer, to its Board of Directors, effective November 1, 2026.

Fonseca built Pfizer's enterprise AI program from inception

Fonseca served as Pfizer's Chief Digital and Technology Officer from January 2019 to April 2026. She led the company's enterprise AI, digital, data and technology strategy, as well as Learning & Development and Business Process Excellence. She scaled the AI program across the enterprise, contributing to significant growth and cost savings.

She now serves as Senior Advisor to Pfizer's Chief Executive Officer and sits on the Board of Directors of Medtronic plc.

Sciensus names ex-HC-One chief James Tugendhat as CEO

Image
Sciensus names ex-HC-One chief James Tugendhat as CEO

London – October 29, 2026 -- Sciensus has appointed James Tugendhat OBE as Chief Executive Officer, bringing in an executive with more than 20 years of leadership experience across healthcare and complex service organisations.

Former HC-One group CEO replaces interim chief Gordon Cox

Tugendhat was most recently Group CEO of HC-One, the UK's largest care home operator. He previously held senior positions at Bupa, including CEO of Health Dialog, a US health analytics and chronic disease management company. He also spent seven years as a non-executive director of the Royal Free London NHS Foundation Trust.

Gordon Cox led Sciensus as interim CEO while the Board searched for a permanent successor. Cox continues as Chief Operating Officer and as a member of key company boards.

RealReal Hires eBay's $10B Fashion Leader as Merchandising Chief

Image
RealReal Hires eBay's $10B Fashion Leader as Merchandising Chief

San Francisco – October 29, 2026 -- The RealReal (Nasdaq: REAL) has appointed Alexis Hoopes, who led eBay's $10 billion global fashion business, as Chief Merchandising Officer, handing her control of the luxury resale marketplace's merchandising strategy.

Hoopes to focus on luxury assortment, personalized discovery and supply growth

Hoopes will lead merchandising strategy with three stated priorities: strengthening the luxury assortment, improving personalized product discovery, and opening new growth opportunities through technology, data and global marketplace expertise. She said she intends to expand the assortment and unlock new sources of supply.

CEO Rati Sahi Levesque cited Hoopes' "rare combination of luxury merchandising expertise, global marketplace experience and operational discipline."

Quarterra Names Jeb Cox to Lead Texas Multifamily Development

Image
Quarterra Names Jeb Cox to Lead Texas Multifamily Development

CHARLOTTE – October 29, 2026 -- Quarterra has appointed Jeb Cox, whose career spans nearly 14,000 apartment homes and more than $2.1 billion in capitalization, as Managing Director of Development, Texas.

Cox takes charge of the full development cycle across Texas

Cox will oversee new multifamily development initiatives statewide and lead a divisional team through every project phase. Those phases are land sourcing, entitlements, capitalization, design and construction execution, optimizing marketability and operability, lease-up and disposition.

Cox brings nearly 20 years of institutional multifamily experience

Cox has spent nearly 20 years leading development of institutional-quality multifamily communities. He spent more than a decade at Mill Creek Residential before joining Quarterra, and previously served at Trammell Crow Residential and Creekstone Partners.

ImpediMed Names Nicole Stout Chief Clinical Innovation Officer

Image
ImpediMed Names Nicole Stout Chief Clinical Innovation Officer

Carlsbad – October 29, 2026 -- ImpediMed has appointed Nicole L. Stout, DPT, CLT-LANA, FAPTA, as Chief Clinical Innovation Officer, effective November 1, 2026, to speed adoption of its SOZO Digital Health Platform in cancer survivorship care.

Stout will lead clinical strategy, research, medical affairs and key opinion leader engagement. Her mandate is to expand use of the platform across care settings.

Stout's research helped establish the Prospective Surveillance Model

Stout has spent more than 25 years in cancer rehabilitation and survivorship. Her research helped build the evidence base for the Prospective Surveillance Model (PSM), which pairs pretreatment baseline assessments with risk-stratified interval monitoring. Patients are referred to supportive care when changes appear.

CHC Taps TORCH CEO John Henderson as SVP of Hospital Operations

Image
CHC Taps TORCH CEO John Henderson as SVP of Hospital Operations

Plano, Texas – October 29, 2026 -- Community Hospital Corporation (CHC) will bring in John Henderson, who has led the Texas Organization of Rural & Community Hospitals (TORCH) since 2018, as Senior Vice President of Hospital Operations in January 2027.

Henderson's TORCH record includes $250M in targeted Medicaid rates

Henderson has spent more than eight years advocating for and supporting all 155 rural hospitals in Texas through TORCH. In 2023 he secured $250M in targeted Medicaid rates. During the 2025 Texas legislative session he led advocacy for the rural OB rate enhancement and HB 18.

On TORCH's own finances, he turned an initial loss into seven consecutive years of gains and quadrupled cash and investments.

Clean Energy Ventures Names Aruna Ramsamy Managing Partner

BOSTON – October 29, 2026 -- Clean Energy Ventures (CEV), a venture capital firm investing in climate technologies in North America and Europe, has appointed Aruna Ramsamy as Managing Partner to lead its European operations from London.

CEV targets early-growth and growth-stage deals with the new hire

The appointment is meant to expand CEV's capabilities in early-growth and growth-stage investing, deepen its European presence and add experience for its active portfolio companies. Ramsamy will identify, assess and structure new investments, guide portfolio companies through growth inflection points and contribute to the growth of CEV's asset management platform.